The Best Short Squeeze Candidate You'll Find Right Now. Shorts Are Truly Trapped.

Vroom, Inc. Common Stock (VRM) recently re-listed after going through bankruptcy proceedings. This is truly the greatest short squeeze candidate you'll find right now as it is a highly shorted, low float and low volume play. Shorts are truly trapped. Stats from Yahoo Finance:













There are 240,000 shares short on the stock with a float of only 427,000. Unlike so many other stocks with "small" floats like this but trade millions of shares a day, VRM has averaged only 25,000 shares traded per day since re-listing. That's a sign that the trading is real and not being manipulated by bots and market makers. Shorts likely shorted that heavily thinking that bankruptcy would result in a de-listing and the stock being worthless. But that clearly didn't happen. Now they are stuck with a short position on a stock that hardly has any volume and it's impossible to exit without significantly moving VRM upward. This is one of those rare times where retail buying can actually cause a squeeze. 

VRM has 5.1 million shares outstanding. Mudrick Capital owns 3.9 million of them. So there is heavy insider ownership and incentive to see the stock price rise. There are also warrants on the stock at $60.95. VRM exited the bankruptcy with an improved balance sheet and $58 million in excess liquidity. Dilution this soon out of the bankruptcy proceeding appears unnecessary and unlikely. VRM's float will be that low for a while. This one looks like the best true short squeeze candidate right now. 

The last stock that we saw trade like this was Logistic Properties of the Americas (LPA), which rose from less than $20 to over $500 in a few trading days at the end of last year on hardly any volume. This is the type of performance that can happen with a low float, low volume stock with high short interest.







Comments

Post a Comment

Popular posts from this blog

The Two Best Biotech Short Squeeze Candidates And The Next Carvana

Image
With the market having recovered most of its recent drop to be near all-time highs once again, shorts have been destroyed and are in a desperate spot. Heavily shorted stocks like B. Riley Financial, Inc. (RILY), Globe Life Inc. (GL) and Carvana Co. (CVNA) have been on absolute tears. We have written about CVNA before , as well as the impact of CVNA's move on Root , Inc. (ROOT). When a stock is squeezing like CVNA, a related stock like ROOT will follow suit. Shorts are often shorting multiple related stocks. Most don't even hide it with Kerrisdale openly bragging about its poor track record. GL was another one that was attacked by shorts which we talked about as a gamma squeeze candidate that has worked out very well over the past three weeks.  In this market of short squeezes, we have identified two excellent biotech short squeeze candidates, ImmunityBio, Inc. (IBRX) and Soleno Therapeutics, Inc. (SLNO). IBRX is starting up the production and sale of its cancer drug ANKT...
Read more

Globe Life: Gamma Squeeze Heading Into Earnings

Image
Last week Globe Life (GL) tanked on some half-assed short report by someone called Fuzzy Panda Research. This was a blatant attempt at manipulation and it worked. Unusual Whales reported that large put option positions were being opened, including a $500,000 position in May $80 puts that was closed five hours later for $5 million. It looks like a coordinated attack with a short report that wasn't particularly strong between buddies on Wall Street. That leaves retail put option holders holding the bag as thousands of puts worth of open interest at strikes below $60 are now set to expire worthless.  The more interesting play will be the gamma squeeze potential heading into earnings. GL will be reporting its Q1 after close on Monday the 22nd. Despite a very weak market this week, GL's upward momentum has been accelerating. Since closing at its low of $49.17 on April 11, it has risen 28% to $63, with Tuesday and Wednesday (so far) increasing in excess of 5%. This creates a problem...
Read more